Abstract:Background Hepatocyte carcinoma (HCC) is one of the most common malignancies worldwide. Despite many achievements in diagnosis and treatment, HCC mortality remains high due to the malignant nature of the disease. Novel approaches, especially for targeted therapy, are being extensively explored. Gene therapy is ideal for such purpose for its specific expression of exogenous genes in HCC cells driven by tissue-specific promoter. However strategies based on correction of mutations or altered expressions of genes responsible for the development/progression of HCC have limitations because these aberrant molecules are not presented in all cancerous cells. In the current work, we adopted a novel strategy by targeting the DNA replication step which is essential for proliferation of every cancer cell. Methods A recombinant adenovirus with alpha fetoprotein (AFP) promoter-controlled expressions of artificial microRNAs targeting DNA polymerases α, δ, ε and recombinant active Caspase 3, namely Ad/AFP-Casp-AFP-amiR, was constructed. Results The artificial microRNAs could efficiently inhibit the expression of the target polymerases in AFP-positive HCC cells at both RNA and protein levels, and HCC cells treated with the recombinant virus Ad/AFP-Casp-AFP-amiR exhibited significant G0/1 phase arrest. The proliferation of HCC cells were significantly inhibited by Ad/AFP-Casp-AFP-amiR with increased apoptosis. On the contrary, the recombinant adenovirus Ad/AFP-Casp-AFP-amiR did not inhibit the expression of DNA polymerases α, δ or ε in AFP-negative human normal liver cell HL7702, and showed no effect on the cell cycle progression, proliferation or apoptosis. Conclusions Inhibition of DNA polymerases α, δ and ε by AFP promoter-driven artificial microRNAs may lead to effective growth arrest of AFP-positive HCC cells, which may represent a novel strategy for gene therapy by targeting the genes that are essential for the growth/proliferation of cancer cells, avoiding the limitations set by any of the individually altered gene.

Experimental Cancer Gene Therapy by Multiple Anti-Survivin Hammerhead Ribozymes

A New Oncolytic Adenoviral Vector Carrying Dual Tumour Suppressor Genes Shows Potent Anti-Tumour Effect

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

The Hammerhead Ribozyme Mediated Repression of VEGF for Cancer Gene Therapy

DNA Polymerases as targets for gene therapy of hepatocellular carcinoma

A Survivin Double Point Mutant Has Potent Inhibitory Effect on the Growth of Hepatocellular Cancer Cells

Effective Gene-Viral Therapy For Telomerase-Positive Cancers By Selective Replicative-Competent Adenovirus Combining With Endostatin Gene

Construction of a Novel Vector Expressing Survivin-shRNA and Fusion Suicide Gene Ycdglytk and Its Application in Inhibiting Proliferation and Migration of Colon Cancer Cells

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

Lentivirus-mediated Gene Therapy by Suppressing Survivin in BALB/c Nude Mice Bearing Oral Squamous Cell Carcinoma.

Antitumor Activity of an Adenovirus Harboring Two Therapeutic Genes, Anti-Vegf Ribozyme and Human IL-24, in Colon Cancer.

Gene-Viral Cancer Therapy Using Dual-Regulated Oncolytic Adenovirus with Antiangiogenesis Gene for Increased Efficacy

Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant

Levels Of Effectiveness Of Gene Therapies Targeting Survivin And Its Splice Variants In Human Breast Cancer Cells

Survivin Knockdown by Short Hairpin RNA Abrogates the Growth of Human Hepatocellular Carcinoma Xenografts in Nude Mice.

[Specific Killing Effects of Combination of Double Suicide Gene and Survivin Antisense Oligonucleotide on Breast Tumor Cells and Vein Endothelial Cells].

Enhancing tumor radiosensitivity by intracellular delivery of survivin antagonists.

Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease

A Triple-Regulated Oncolytic Adenovirus Carrying MicroRNA-143 Exhibits Potent Antitumor Efficacy in Colorectal Cancer.

Improved Radiotherapy by Survivin Small Hairpin RNA Trigger Apoptosis of Human Lung Adenocarcinoma Via Caspase-3 Upregulation in Vitro and in Vivo

Enhancement of Cancer Cell Radiosensitivity by Adenovirus Vector Carrying Sirna of Survivin Gene